What is considered the first significant revolution in bladder cancer research in the past 30 years has been announced in a study published on the 27th of November. This new breakthrough drug for bladder cancer falls under the family of immunotherapy and is currently known as MPDL3280A, declared as the first and only alternative to chemotherapeutic practices in the present. Cancer is currently … [Read more...]
Decade-old cheap drug extends lives of men with Prostate Cancer: Study
A decade –old cheap drug for chemotherapy was found to have extended life among those men who suffer from prostate cancer, a study says. According to the researchers, when the drug was added to standard hormone therapy, the life of these cancer patients got extended by more than a year. The drug docetaxel (doe-suh-TAX-uhl) allowed these cancer patients to live nearly 58 months. During … [Read more...]
